Allegheny Health Network Celebrates FDA Approval of a New Treatment for Lupus
December 8th 2021Patients at AHN’s Autoimmunity Institute participated in international clinical trial testing of Saphnelo™ (anifrolumab) – the first new biologic agent in more than a decade for the treatment of adult patients with moderate to severe lupus.
Read More